Skip to content

Efficacy of epinastine hydrochloride ophthalmic solution in patients with allergic conjunctivitis

Efficacy of epinastine hydrochloride ophthalmic solution in patients with allergic conjunctivitis - Efficacy of epinastine hydrochloride ophthalmic solution in patients with allergic conjunctivitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016313
Enrollment
50
Registered
2015-02-01
Start date
2015-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic conjunctivitis

Interventions

Sponsors

Watanabe eye clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with moderate (*)and more moderate eye itching at the time of obtaining informed consent *Moderate: score 2 or more in five rated below 0: No symptoms, 1: mild, 2: slightly heavy, 3: heavy, 4: Very heavy 2)Patients scheduled for wearing the same product of contact lenses if they are wearing contact lenses during the test period.

Exclusion criteria

Exclusion criteria: 1)Females who are or may be pregnant, or lactating 2)Patients with a history of hypersensitivity to study drug or test material 3)Patient who the investigator considers ineligible for enrolment.

Design outcomes

Primary

MeasureTime frame
Change in scores of subjective symptoms Change in scores of objective findings

Countries

Japan

Contacts

Public ContactKiyoshi Watanabe

Watanabe eye clinic Watanabe eye clinic

watanabe@jpncl.com06-6456-4455

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026